Contributors

Ed Silverman has been a reporter for more than 20 years, the last 11 as a pharmaceutical business reporter at the The Star-Ledger. He worked on Wall Street before switching to journalism, and previously wrote for publications including New York Newsday and BusinessWeek. On page 40, he writes about challenges faced by university tech transfer offices. "They have a tough job," he says. "They need to make sure that they get the best deal for the university without alienating their

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Ed Silverman has been a reporter for more than 20 years, the last 11 as a pharmaceutical business reporter at the The Star-Ledger. He worked on Wall Street before switching to journalism, and previously wrote for publications including New York Newsday and BusinessWeek. On page 40, he writes about challenges faced by university tech transfer offices. "They have a tough job," he says. "They need to make sure that they get the best deal for the university without alienating their own faculty, industry people, or investors."

Freelancer Brendan Borrell received a PhD in integrative biology from the University of California, Berkeley, in 2006. His work has appeared in The Oregonian, Technology Review, Science Now, and Wired News. On page 20, he chronicles the travails of prolific Danish ornithologist Anders Møller, who has been investigated for scientific fraud. Borrell finds it surprising that although Møller's writing is "very strongly-worded" and "overconfident," ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies